Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-12-09
1983-03-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424251, 424319, A61K 31195, A61K 31495, A61K 31505
Patent
active
043767729
ABSTRACT:
Piperazinyl-imidazo[1,2-a]pyrazines and their acid addition salts are selective .alpha..sub.2 -adrenergic receptor antagonists and are thereby useful for treating sedation caused by antihypertensive drug therapy.
REFERENCES:
patent: 4078063 (1978-03-01), Lumma et al.
patent: 4081542 (1978-03-01), Lumma et al.
patent: 4082844 (1978-04-01), Lumma et al.
patent: 4242344 (1980-12-01), Lumma
Birch et al., Br. J. Pharmacol., 68, 107p (1979).
Drew et al., Br. J. Pharmacol., 67, 133 (1979).
Clineschmidt et al., Arch. Int. Pharmacodyn. Ther., 244, 231 (1980).
Autret et al., Eur. J. Pharmacol., 12, 319 (1977).
Huff Joel R.
Saari Walfred S.
Friedman Stanley J.
Merck & Co. , Inc.
Monaco Mario A.
Nicholson William H.
LandOfFree
Use of piperazinyl-imidazo[1,2-a]pyrazines in sedation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of piperazinyl-imidazo[1,2-a]pyrazines in sedation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of piperazinyl-imidazo[1,2-a]pyrazines in sedation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658441